Related references
Note: Only part of the references are listed.Clinical utility of fractional exhaled nitric oxide in severe asthma management
Andrew Menzies-Gow et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Using fractional exhaled nitric oxide to guide step-down treatment decisions in patients with asthma: a systematic review and individual patient data meta-analysis
Kay Wang et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Fractional Exhaled Nitric Oxide (FENO) in the management of asthma: a position paper of the Italian Respiratory Society (SIP/IRS) and Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC)
Enrico Heffler et al.
MULTIDISCIPLINARY RESPIRATORY MEDICINE (2020)
Does treatment guided by exhaled nitric oxide fraction improve outcomes in subgroups of children with asthma?
Shona S. Fielding et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Scottish consensus statement on the role of FeNO in adult asthma
Chris RuiWen Kuo et al.
RESPIRATORY MEDICINE (2019)
Tailoring asthma treatment on eosinophilic markers (exhaled nitric oxide or sputum eosinophils): a systematic review and meta-analysis
Helen L. Petsky et al.
THORAX (2018)
A European Respiratory Society technical standard: exhaled biomarkers in lung disease
Ildiko Horvath et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
Utilising exhaled nitric oxide information to enhance diagnosis and therapy of respiratory disease - current evidence for clinical practice and proposals to improve the methodology
Marieann Hoegman et al.
EXPERT REVIEW OF RESPIRATORY MEDICINE (2017)
Revisiting Type 2-high and Type 2-low airway inflammation in asthma: current knowledge and therapeutic implications
D. Robinson et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2017)
Evaluation of switching low-dose inhaled corticosteroid to pranlukast for step-down therapy in well-controlled patients with mild persistent asthma
Sonoko Harada et al.
JOURNAL OF ASTHMA (2016)
Step-down treatment from medium-dosage of budesonide/formoterol in controlled asthma
Kazutaka Mori et al.
RESPIRATORY MEDICINE (2016)
Emerging molecular phenotypes of asthma
Anuradha Ray et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2015)
Contribution of exhaled nitric oxide measurement in airway inflammation assessment in asthma. A position paper from the French Speaking Respiratory Society
A. T. Dinh-Xuan et al.
REVUE DES MALADIES RESPIRATOIRES (2015)
Type 2 inflammation in asthma - present in most, absent in many
John V. Fahy
NATURE REVIEWS IMMUNOLOGY (2015)
Exhaled nitric oxide and inhaled corticosteroid dose reduction in asthma: a cohort study
Emma Wilson et al.
EUROPEAN RESPIRATORY JOURNAL (2014)
Nitric oxide synthases: regulation and function
Ulrich Foerstermann et al.
EUROPEAN HEART JOURNAL (2012)
A systematic review and meta-analysis: tailoring asthma treatment on eosinophilic markers (exhaled nitric oxide or sputum eosinophils)
H. L. Petsky et al.
THORAX (2012)
An Official ATS Clinical Practice Guideline: Interpretation of Exhaled Nitric Oxide Levels (FENO) for Clinical Applications
Raed A. Dweik et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Use of beclomethasone dipropionate as rescue treatment for children with mild persistent asthma (TREXA): a randomised, double-blind, placebo-controlled trial
Fernando D. Martinez et al.
LANCET (2011)
The Predicting Response to Inhaled Corticosteroid Efficacy (PRICE) trial
Richard J. Martin et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2007)
Long-acting β2-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma -: A randomized controlled trial
SC Lazarus et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Share Paper
